(Q36316655)

13 August 2017

1 reference

title

Commercial challenges of protein drug delivery (English)

1 reference

13 August 2017

1 reference

Larry R Brown

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Expert Opinion on Drug Delivery

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

29-42

1 reference

Oliver Memorial Lecture 1989. The evolution and future of haemophilia therapy

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Oral delivery of proteins: progress and prognostication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Alternative routes of insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Concept, strategies, and feasibility of noninvasive insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

21 January 2018

The GnRH pulse generator

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Somatostatin analogs for cancer treatment and diagnosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

A month-long effect from a single injection of microencapsulated human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Precise control of PLG microsphere size provides enhanced control of drug release rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Peptide and protein PEGylation: a review of problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Darbepoetin-alpha: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Clinical testing results and high patient satisfaction with a new needle-free device for growth hormone in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.1.29

21 January 2018

Identifiers

DOI

10.1517/17425247.2.1.29

1 reference

13 August 2017

1 reference